Physician profile
Anthony Stuart
NPI 1508839788
$3,757.04
in general payments reported to CMS, 2019-2025
39 companies · $749 in 2025
The $749 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,054 · 2020: $117 · 2021: $56.68 · 2022: $241 · 2023: $805 · 2024: $735 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,288.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $649.39 | 2019-2025 | |
| Glaxosmithkline, LLC. | $479.88 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $353.14 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Novo Nordisk INC | $261.98 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Lilly USA, LLC | $257.98 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Janssen Pharmaceuticals, INC | $162.30 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $160.33 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Dexcom, INC. | $132.77 | 2022-2025 | Dexcom G6 Transmitter |
| Allergan, INC. | $110.22 | 2019 | |
| Abbvie INC. | $96.84 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $94.80 | 2019-2025 | Xifaxan |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.30 | 2024-2025 | |
| Corcept Therapeutics | $78.69 | 2025 | Korlym |
| Phathom Pharmaceuticals, INC. | $70.77 | 2024 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $69.18 | 2023-2024 | Rexulti |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $59.34 | 2019-2024 | Evenity, Prolia |
| Xeris Pharmaceuticals, INC. | $45.35 | 2024-2025 | Keveyis, Gvoke Hypopen |
| Avanir Pharmaceuticals, INC. | $45.29 | 2019 | |
| Novartis Pharmaceuticals Corporation | $40.97 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.80 | 2021 | |
| Insulet Corporation | $36.84 | 2025 | Omnipod |
| Abiomed | $36.76 | 2024-2025 | Impella |
| Viatris Specialty LLC | $35.66 | 2025 | Yupelri |
| Daiichi Sankyo INC. | $33.87 | 2020-2023 | Injectafer |
| Astellas Pharma US INC | $32.37 | 2023-2024 | Veozah |
| Abbott Laboratories | $31.02 | 2023 | Freestyle Libre 3 |
| Mallinckrodt Hospital Products INC. | $27.93 | 2023 | Terlivaz |
| Idorsia Pharmaceuticals US INC | $27.38 | 2023 | Quviviq |
| E.R. Squibb & Sons, L.L.C. | $25.10 | 2019 | |
| Sanofi-Aventis U.S. LLC | $24.61 | 2019 | |
| Mylan Specialty L.P. | $22.35 | 2024 | Yupelri |
| Vifor Pharma, INC. | $18.89 | 2023 | Veltassa |
| Ultragenyx Pharmaceutical INC. | $17.60 | 2024 | Crysvita |
| Verona Pharma, INC. | $16.96 | 2025 | Ohtuvayre |
| Exact Sciences Corporation | $16.39 | 2023 | Cologuard Collection Kit |
| Lundbeck LLC | $16.17 | 2023 | Rexulti |
| Inogen, INC. | $14.06 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Shield Therapeutics INC | $13.42 | 2024 | |
| Itamar Medical INC | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Stuart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.